FDA approves Rocket gene therapy for rare immune disorder
Posted:
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
GIANT Health is delighted to welcome XR Therapeutics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase how immersive technology is helping transform mental health care across the NHS.
Mental health services…
GIANT Health is pleased to welcome Psyomics to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where they will showcase their innovative approach to improving mental health services through better information, earlier understanding and more informed…
Attendees
Sponsors and Exhibitors
Contact us